Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2017 | How can doctors discuss CLL treatment options with patients?

Clemens Wendtner • 27 Mar 2017
BSH 2017
Chronic Lymphocytic Leukemia

Clemens Wendtner, MD from the University of Cologne, Cologne, Germany, advises doctors on how to discuss different treatment options with chronic lymphocytic leukemia (CLL) patients at the British Society for Haematology (BSH) Annual Scientific Meeting in 2017 in Brighton, UK. He highlights the value of calming patients by pointing out that a number of choices are available, but speaks about the importance of patience, as not all CLL patients need to be treated.

More from Clemens Wendtner

1:17
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Clemens Wendtner • 27 Mar 2017
1:27
Current and future CLL diagnostic tools
Clemens Wendtner • 27 Mar 2017
1:39
Overview of the CLLR3 trial of obinutuzumab
Clemens Wendtner • 16 Sep 2016
2:09
Tsunami of evidence in CLL
Clemens Wendtner • 16 Sep 2016

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
The content of VJHemOnc is intended for healthcare professionals